CAPTRUST Financial Advisors
XGN icon

CAPTRUST Financial Advisors’s Exagen XGN Stock Holding History

CAPTRUST Financial Advisors’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-340
Closed -$2K – 4095
2022
Q2 		$2K Hold
340
– – ﹤0.01% 4527
2022
Q1 		$3K Hold
340
– – ﹤0.01% 4399
2021
Q4 		$4K Hold
340
– – ﹤0.01% 4201
2021
Q3 		$5K Hold
340
– – ﹤0.01% 3965
2021
Q2 		$5K Buy
+340
New +$5.21K ﹤0.01% 3881

Other funds holding XGN

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CAPTRUST Financial Advisors's XGN Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Exagen (XGN) in Q3 2022, closing a stake of 340 shares — an estimated $2K sold.

CAPTRUST Financial Advisors first reported a position in XGN in Q2 2021 and held it in 5 quarters. The position peaked at $5K in Q3 2021. 38 funds tracked by Wall St. Rank hold XGN as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Exagen position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 340 Exagen shares in Q3 2022, an estimated $2K.
  • CAPTRUST Financial Advisors first reported a position in Exagen in Q2 2021 and held it in 5 quarters.
  • CAPTRUST Financial Advisors's Exagen position peaked at $5K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Exagen as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.